Related Experiment Video
Updated: Jan 26, 2026

Reducing State Anxiety Using Working Memory Maintenance
Published on: July 19, 2017
Validation of the Geriatric Anxiety Inventory in Chilean older people
Claudia Miranda-Castillo1, Daniel Contreras2, Karin Garay2
1Universidad Andres Bello, Faculty of Nursing, Sazié 2212, Santiago, Chile; Millennium Institute for Research in Depression and Personality, Av. Vicuña Mackenna 4860, Macul, Santiago, Chile.
Objective:
Currently in Chile there is a lack of validated tools for measuring anxiety in the elderly population. Considering this, the purpose of this study was to validate the Geriatric Anxiety Inventory (GAI) in the country.
Method:
An analysis of the psychometric properties of the GAI was carried out, using a non-clinical sample of 301 older adults in the Metropolitan and Valparaíso regions of Chile. Older people were asked about anxiety, rumination, depression, well-being and sociodemographic data.
Results:
An excellent internal reliability was obtained with a Cronbach score of 0.931. An adequate convergent validity was observed with the Depression scales (CES-D) (Rho = 0.549, p < .01), Rumination (RSS) (Rho = 0.618; p < 0.01) and Experiential avoiding (Rho = 0.485; p < 0.01). On the other hand, the discriminant validity of the psychological well-being scale presented a negative correlation of Rho = -0.699 (p < 0.01). Finally, and Exploratory Factor Analysis was made, revealing a one-dimensional model of the instrument.
Conclusion:
The Geriatric Anxiety Inventory has very good psychometric properties measuring anxiety in elderly people, being an adequate instrument for the screening of anxiety on this population.
Related Concept Videos
Reliability and Validity
Anxiety: Overview
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Generalized Anxiety Disorder
Drug Dosing: Geriatric Patients
Social Anxiety Disorder
Pharmacodynamics in Geriatric Patients: Effects of Age

